Virtu Financial LLC purchased a new position in CME Group Inc (NASDAQ:CME) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 3,563 shares of the financial services provider’s stock, valued at approximately $607,000.

Several other large investors have also added to or reduced their stakes in CME. FDx Advisors Inc. bought a new stake in CME Group in the third quarter valued at about $390,000. Edgewood Management LLC increased its holdings in CME Group by 9.5% in the third quarter. Edgewood Management LLC now owns 8,582,518 shares of the financial services provider’s stock valued at $1,460,830,000 after buying an additional 742,067 shares during the last quarter. Independent Advisor Alliance bought a new stake in CME Group in the third quarter valued at about $208,000. Boston Private Wealth LLC increased its holdings in CME Group by 425.2% in the third quarter. Boston Private Wealth LLC now owns 91,850 shares of the financial services provider’s stock valued at $15,633,000 after buying an additional 74,360 shares during the last quarter. Finally, D.A. Davidson & CO. increased its holdings in CME Group by 1.7% in the third quarter. D.A. Davidson & CO. now owns 29,907 shares of the financial services provider’s stock valued at $5,091,000 after buying an additional 500 shares during the last quarter. Institutional investors and hedge funds own 85.89% of the company’s stock.

NASDAQ:CME opened at $187.11 on Friday. The company has a market cap of $64.24 billion, a PE ratio of 39.23, a P/E/G ratio of 2.19 and a beta of 0.46. CME Group Inc has a 52 week low of $143.68 and a 52 week high of $197.08. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.09 and a quick ratio of 1.09.

CME Group (NASDAQ:CME) last posted its earnings results on Thursday, October 25th. The financial services provider reported $1.45 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.42 by $0.03. The company had revenue of $904.20 million during the quarter, compared to analyst estimates of $910.50 million. CME Group had a return on equity of 9.18% and a net margin of 113.67%. Equities research analysts anticipate that CME Group Inc will post 6.66 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 27th. Stockholders of record on Monday, December 10th will be issued a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a dividend yield of 1.50%. The ex-dividend date of this dividend is Friday, December 7th. CME Group’s dividend payout ratio (DPR) is presently 58.70%.

Several analysts recently weighed in on the company. Barclays assumed coverage on CME Group in a report on Tuesday. They issued an “overweight” rating and a $210.00 price objective for the company. Zacks Investment Research lowered CME Group from a “buy” rating to a “hold” rating in a report on Friday. Atlantic Securities assumed coverage on CME Group in a report on Wednesday, November 28th. They issued a “neutral” rating and a $200.00 price objective for the company. BidaskClub raised CME Group from a “buy” rating to a “strong-buy” rating in a report on Tuesday, October 9th. Finally, Deutsche Bank boosted their price objective on CME Group from $205.00 to $206.00 and gave the company a “buy” rating in a report on Friday, November 16th. Six equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $194.13.

In other news, insider Julie Winkler sold 5,847 shares of the business’s stock in a transaction that occurred on Friday, November 16th. The stock was sold at an average price of $195.01, for a total transaction of $1,140,223.47. Following the completion of the transaction, the insider now directly owns 24,255 shares in the company, valued at $4,729,967.55. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Martin J. Gepsman sold 300 shares of the business’s stock in a transaction that occurred on Thursday, September 13th. The stock was sold at an average price of $172.30, for a total value of $51,690.00. Following the transaction, the director now owns 42,912 shares of the company’s stock, valued at $7,393,737.60. The disclosure for this sale can be found here. Insiders have sold 29,800 shares of company stock valued at $5,628,462 over the last ninety days. Corporate insiders own 0.43% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Virtu Financial LLC Invests $607,000 in CME Group Inc (CME)” was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this article on another website, it was illegally stolen and republished in violation of U.S. and international copyright law. The legal version of this article can be viewed at https://www.watchlistnews.com/virtu-financial-llc-invests-607000-in-cme-group-inc-cme/2671019.html.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Further Reading: Diversification For Individual Investors

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.